Dh. Li et al., EFFECTS OF CHRONIC ADMINISTRATION OF TAMOXIFEN AND TOREMIFENE ON DNA-ADDUCTS IN RAT-LIVER, KIDNEY, AND UTERUS, Cancer research, 57(8), 1997, pp. 1438-1441
To assess the effects of chronic administration of tamoxifen (TAM) and
toremifene (TOR) on genetic damage related to carcinogenesis, we meas
ured DNA adduct formation by P-32-postlabeling in liver, kidney, and u
terus of Fischer rats gi,en TAM or TOR in the diet for 18 months, TAM
induced high levels of DNA adducts in the liver in a dose-dependent ma
nlier, The total adduct levels were 3000 +/- 870 and 6100 +/- 1500 add
ucts per 10(9) nucleotides for the 250- and 500-ppm groups, respective
ly, TOR induced a dose-dependent level of adducts that was lower than
that observed for TAM. The total hepatic adduct level was 70 +/- 5, 13
0 +/- 20, and 70 +/- 20 for 250, 500, and 750 ppm TOR, respectively, B
oth TAM and TOR induced a low level of adducts in the kidney, and TOR
significantly enhanced endogenous DIVA adduct formation, The total add
uct level was 480 +/- 140, 420 +/- 210, and 680 +/- 80 adducts per 10(
9) nucleotides for control, 500 ppm TAM, and 500 ppm TOR, respectively
. Although neither TAR;I nor TOR induced adducts in the uterus, TAM si
gnificantly enhanced endogenous DNA modifications in this tissue, The
total uterine adduct level was 70 +/- 30, 130 +/- 50, and 70 +/- 20 fo
r control, 500 ppm T-IRI, and 500 ppm TOR. respectively, These observa
tions demonstrate a correlation between DNA adduct formation and carci
nogenicity fur these compounds, The effectiveness of TOR and TAM in in
creasing endogenous DNA adducts indicates that a mechanism other than
direct DNA damage may also he involved in their carcinogenicity.